# FDA recall D-0222-2024

> **Rising Pharma Holding, Inc.** · Class II · drug recall initiated 2023-12-29.

## Product

buPROPion Hydrochloride Extended-Release Tablets, USP (XL) 150mg, 30-count bottles, Rx Only, Manufactured for: Rising Pharma Holdings, Inc. East Brunswick, NJ 08816 Manufactured by: Graviti Pharmaceuticals Pvt. Ltd. Telangana - 502307, INDIA, NDC 16571-862-03

## Reason for recall

Presence of Foreign Tablets/Capsules

## Distribution

Nationwide within the United States

## Key facts

- **Recall number:** D-0222-2024
- **Recalling firm:** Rising Pharma Holding, Inc.
- **Classification:** Class II
- **Product type:** drug
- **Status:** Ongoing
- **Initiation date:** 2023-12-29
- **Report date:** 2024-01-17

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** East Brunswick, NJ, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0222-2024

## Citation

> MORVS. FDA recall D-0222-2024. Retrieved 2026-10-16 from https://api.morvs.ai/recall/D-0222-2024. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*